lupus.bmj11d
Intermediate monocytes in blood correlate with subclinical vascular changes in lupus nephritis
Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...
lupus.bmj5d
Association of race and ethnicity with mortality in adults with SLE: a systematic literature review and meta-analysis
Objectives Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. SLE is a disease ...
lupus.bmj5d
Time trends of variability in disease activity in systemic lupus erythematosus
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
lupus.bmj4d
Prediction of mortality risk in critically ill patients with systemic lupus erythematosus: a machine learning approach using the MIMIC-IV database
Objective Early prediction of long-term outcomes in patients with systemic lupus erythematosus (SLE) remains a great challenge in clinical practice. Our study aims to develop and validate predictive ...
lupus.bmj6d
Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
lupus.bmj5d
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis. Phase II studies have shown promising results, although long-term data are ...
lupus.bmj4d
Current Issue
Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials (6 January, 2025) ...
lupus.bmj26d
Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus
Objective Osteoporosis is a common comorbidity in patients with SLE, and bone loss in patients with SLE has a multifactorial aetiology. This study aimed to evaluate the therapeutic efficacy of ...